Association between the Length of Hospital Stay and 30-Day Outcomes in Patients Admitted with Acute Decompensated Heart Failure

Table 9

Drugs administered for patients during hospitalization divided by the tertiles of LOS. significant between group difference.

	Length of hospital stay
	<4	4–6	>6
	Number (Percentage)
ACEIs	48 (24.4%)	77 (39.1%)	72 (36.5%)
ARBs	44 (26.7%)	70 (42.4%)	51 (30.9%)
Beta blockers	84 (27.3%)	119 (38.6%)	105 (34.1%)
Diuretics	93 (26.1%)	137 (38.5%)	126 (35.4%)
MRAs	38 (25.2%)	63 (41.7%)	50 (33.1%)
Statins	55 (24.6%)	93 (41.5%)	76 (33.9%)
Inotropes	5 (11.1%)	16 (35.6%)	24 (53.3%)
Nitrates	6 (22.2%)	9 (33.3%)	12 (44.4%)
Aspirin	58 (26.5%)	83 (37.9%)	78 (35.6%)
ADP inhibitors	17 (21.5%)	33 (41.8%)	29 (36.7%)
PPIs	51 (23.5%)	89 (41.0%)	77 (35.5%)

ACEIs, angiotensin converting enzyme inhibitors; ARBs, angiotensin receptor blockers; MRAs, mineralocorticoid receptor antagonists; ADP inhibitors, adenosine diphosphate (ADP) receptor inhibitors; PPI, proton pump inhibitors. Bold values indicate values with significant differences among tertiles of length of hospital stay.